Ninety percent of adult women in the United States are responsible for making the health-care decisions for themselves and their family members.
Georgia law enforcement agencies seize millions of dollars in assets every year from people who are never even charged with, much less convicted of, a crime.
More money for small companies’ biotech R&D, less money for ObamaCare ‘cost savings,’ overworked physicians and more.
It’s not an exchange, it’s the marketplace; what hospital mergers are doing to costs and what XBox Kinect has to do with health care.
One of the top nine biotech trends of 2012 listed in Genetic Engineering and Biology News is the year’s amazing (and sometimes useless?) research.
What happens if your company drops your coverage? If you want to use a private provider instead of Medicare?
What to expect after the November 6 elections: More school choice in Georgia; for the nation, regulations, a fiscal cliff and an entitlement cliff. .
Did you now that between 1992-2009, Georgia’s student population grea 41 percent and school personnel grew 80 percent?
Today: The cost of sick workers, ROI on wellness programs, high-cost drugs and privacy challenges for young adults
What’s in the Foundation’s Plan B for Georgia Transportation? Find out in Friday Facts.
Scientists say two marketed anticancer drugs may one day restore memory in Alzheimer’s patients.
Becker’s Hospital CEO Report quizzed nine health care professionals on how U.S. health care costs have gotten out of control in the past 10-plus years and what more needs to be done
Americans too often lose sight of the longer-term debate about health care when they focus on arguments dictated by the framework of an election cycle and partisan political lines. Hence Heartland Institute’s “Ten Things Everyone Should Read About Health Care.”
Researchers in Scotland have revealed plans to create a revolutionary new hip implant that will use the latest stem cell technology to allow patients to grow their own bone, removing the need for regular replacement surgery.
What does the boss think of the new federal health law? Nearly two-thirds of employers see it as a step in the wrong direction,
By Grace-Marie Turner “No matter how we reform health care, we will keep this promise to the American people: If you like your doctor, you will be able to keep your doctor, period.” President Barack Obama, Speech to the American Medical Association Chicago, June 15, 2009 In truth, prospects are bleak that you will be able to keep your doctor and even bleaker that there will be enough doctors to meet demand under Obamacare. The health overhaul law expands health insurance to millions more people without significantly increasing the number of … Continue Reading →
By Dennis G. Smith The U.S. Supreme Court’s recent decision on the Patient Protection and Affordable Care Act (PPACA) guarantees the debate over health care will continue. Supporters of the PPACA want to convince the public that everything is settled and any opposition is just politics. But opponents are not out to score political points. We believe now, as we did two years ago, that the economic assumptions used in the debate are flawed and the policies are wrong for the nation. Since the court’s decision, the law’s supporters insist … Continue Reading →
By Grace Marie-Turner The latest New York Times / CBS News poll dives into public opinion on ObamaCare following the Supreme Court decision and finds opposition to the law virtually unchanged from when it was enacted in 2010, with about half disapproving and one-third supporting the law. And those who strongly disapprove (36 percent) continue to significantly outnumber those who strongly approve (14 percent) of the law. Support for repeal also remains strong: 61 percent of those polled say they want Congress to repeal the individual mandate (27 percent) or … Continue Reading →
By Benita Dodd Health Policy Briefs: July 17, 2012 – What’s in a name? Another regulatory slugfest: The Generic Pharmaceutical Association is urging the Federal Drug Administration to apply the same nomenclature standards to biosimilar drugs as is used for generic drugs. In an earlier letter, BIO and the Pharmaceutical Research and Manufacturers of America said a biosimilar should not share the name of a biologic product because they are not identical. According to the Kidney Cancer Association, “Biosimilars are sometimes mistakenly called ‘generic’ versions of the original biologic drugs. However, … Continue Reading →
By Ron Bachman Only political junkies really care about the difference between taxes and penalties in the recently validated Patient Protection and Affordable Care Act also known as ObamaCare. All the average American cares about is, “What is it going to cost me?” Republicans can complain that President Obama lied that the health reform costs were not taxes and Democrats can continue the canard that the now constitutionally defined taxes are still penalties. The reality is that are no new costs; they have been there all along. Most Americans just … Continue Reading →